News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
233 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18011)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (4)
2 (9)
3 (212)
4 (215)
5 (173)
6 (226)
7 (87)
9 (6)
10 (122)
11 (224)
12 (187)
13 (207)
14 (83)
15 (2)
16 (12)
17 (193)
18 (233)
19 (194)
20 (207)
21 (84)
22 (4)
23 (9)
24 (192)
25 (205)
26 (236)
27 (269)
28 (70)
30 (5)
31 (190)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
30
31
Business
ImmVira announced to launch the construction of Global R&D and Commercialization Base
On October 18, 2022, ImmVira launched the construction of its Global R&D and Commercialization Base in Suzhou Wuzhong Biomedical Industrial Park, China.
October 18, 2022
·
3 min read
Business
Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer
Abalos Therapeutics announced the appointment of Thomas Bogenrieder, MD, PhD, as Chief Medical Officer.
October 18, 2022
·
3 min read
Bionomics Receives R&D Tax Incentive Refund for FY2022 of A$4.6 million
Bionomics Limited is pleased to announce that the Company has received A$4,634,307.30 research and development tax incentive refund relating to the financial year ended June 2022.
October 18, 2022
·
1 min read
Previous
24 of 24